文献速递妇产影像神经儿科影像MR

孕晚期阿片暴露胎儿的MRI表现:聚焦脑部测量的前瞻性多中心病例对照研究

MRI Findings in Third-Trimester Opioid-Exposed Fetuses, With Focus on Brain Measurements: A Prospective Multicenter Case-Control Study.
PubMed 文献 · AJR Am J Roentgenol · 2022-09-28

调整孕龄、胎儿性别及尼古丁暴露后,阿片暴露组7项脑测量值较小、额枕指数较大,且臀位和羊水增多频率更高。结论提示宫内阿片暴露胎儿脑尺寸较小并存在胎儿生理改变。

要点

  • 孕晚期阿片暴露胎儿多项脑部2D测量值较无暴露胎儿小,包括大脑额枕径、骨双顶径、脑双顶径、胼胝体长度、蚓部高度、脑桥前后径及小脑横径。
  • 阿片暴露胎儿额枕指数较大,臀位和羊水增多出现频率更高,评估时需结合胎位与羊水量。
  • 胎儿运动、宫颈长度及羊水最大垂直暗区两组间无显著差异。

关键影像表现/征象

  • 阿片暴露组较无暴露组大脑额枕径小(93.8±7.4 vs 95.0±8.6 mm,p<.05)。
  • 骨双顶径(79.0±6.0 vs 80.3±7.1 mm)与脑双顶径(72.9±7.7 vs 74.1±8.6 mm)在阿片暴露组较小(p<.05)。
  • 胼胝体长度(37.7±4.0 vs 39.4±3.7 mm)、蚓部高度(18.2±2.7 vs 18.8±2.6 mm)、脑桥前后径(11.6±1.4 vs 12.1±1.4 mm)及小脑横径(40.4±5.1 vs 41.4±6.0 mm)在阿片暴露组较小(p<.05)。
  • 阿片暴露组额枕指数较大(0.04±0.02 vs 0.04±0.02,p=.02)。
  • 阿片暴露组臀位(21% vs 3%,p=.03)及羊水增多(29% vs 8%,p=.04)频率更高,胎儿运动、宫颈长度及羊水最大垂直暗区两组无显著差异(p>.05)。

临床应用与阅片要点

  • 孕晚期胎儿MRI阅片时,若孕妇有阿片暴露史,应关注脑部2D测量值是否偏小,并规范测量额枕径、双顶径、胼胝体长度、蚓部高度、脑桥前后径及小脑横径。
  • 报告时可提示额枕指数增大及臀位、羊水增多等伴随表现,但需结合孕龄、胎儿性别及尼古丁暴露等混杂因素综合判断。

局限性

  • 样本量较小(共65例,阿片暴露组28例),可能影响统计效能。
  • 仅纳入孕晚期胎儿,无法评估更早孕期脑发育变化。
  • 为观察性病例对照研究,不能确立阿片暴露与脑测量差异的因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. The opioid epidemic has profoundly affected infants born in the United States, as in utero opioid exposure increases the risk of cognitive and behavioral problems in childhood. Scarce literature has evaluated prenatal brain development in fetuses with opioid exposure in utero (hereafter opioid-exposed fetuses). OBJECTIVE. The purpose of this study is to compare opioid-exposed fetuses and fetuses without opioid exposure (hereafter unexposed fetuses) in terms of 2D biometric measurements of the brain and additional pregnancy-related assessments on fetal MRI. METHODS. This prospective case-control study included patients in the third trimester of pregnancy who underwent investigational fetal MRI at one of three U.S. academic medical centers from July 1, 2020, through December 31, 2021. Fetuses were classified as opioid exposed or unexposed in utero. Fourteen 2D biometric measurements of the fetal brain were manually assessed and used to derive four indexes. Measurements and indexes were compared between the two groups by use of multivariable linear regression models, which were adjusted for gestational age (GA), fetal sex, and nicotine exposure. Additional pregnancy-related findings on MRI were evaluated. RESULTS. The study included 65 women (mean age, 29.0 ± 5.5 [SD] years). A total of 28 fetuses (mean GA at the time of MRI, 32.2 ± 2.5 weeks) were opioid-exposed, and 37 fetuses (mean GA at the time of MRI, 31.9 ± 2.7 weeks) were unexposed. In the adjusted models, seven measurements were smaller (p < .05) in opioid-exposed fetuses than in unexposed fetuses: cerebral frontooccipital diameter (93.8 ± 7.4 vs 95.0 ± 8.6 mm), bone biparietal diameter (79.0 ± 6.0 vs 80.3 ± 7.1 mm), brain biparietal diameter (72.9 ± 7.7 vs 74.1 ± 8.6 mm), corpus callosum length (37.7 ± 4.0 vs 39.4 ± 3.7 mm), vermis height (18.2 ± 2.7 vs 18.8 ± 2.6 mm), anteroposterior pons measurement (11.6 ± 1.4 vs 12.1 ± 1.4 mm), and transverse cerebellar diameter (40.4 ± 5.1 vs 41.4 ± 6.0 mm). In addition, in the adjusted model, the frontoocccipital index was larger (p = .02) in opioid-exposed fetuses (0.04 ± 0.02) than in unexposed fetuses (0.04 ± 0.02). Remaining measures and indexes were not significantly different between the two groups (p > .05). Fetal motion, cervical length, and deepest vertical pocket of amniotic fluid were not significantly different (p > .05) between groups. Opioid-exposed fetuses, compared with unexposed fetuses, showed higher frequencies of both breech position (21% vs 3%, p = .03) and increased amniotic fluid volume (29% vs 8%, p = .04). CONCLUSION. Fetuses with opioid exposure in utero had a smaller brain size and altered fetal physiology. CLINICAL IMPACT. The findings provide insight into the impact of prenatal opioid exposure on fetal brain development.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Nagaraj, Kline-Fath, Zhang, et al. MRI Findings in Third-Trimester Opioid-Exposed Fetuses, With Focus on Brain Measurements: A Prospective Multicenter Case-Control Study. AJR Am J Roentgenol. 2022. PMID: 36169547. doi:10.2214/AJR.22.28357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。